» Authors » Fiona C McGillicuddy

Fiona C McGillicuddy

Explore the profile of Fiona C McGillicuddy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 1604
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunne S, Gibney E, McGillicuddy F, Feeney E
Proc Nutr Soc . 2024 Feb; 83(4):236-244. PMID: 38316603
CVD is the leading cause of death worldwide, and is commonly associated with modifiable risk factors. Most studies to date examining link between food intake and risk of CVD, have...
2.
Shannon C, Ni Chathail M, Mullin S, Meehan A, McGillicuddy F, Roche H
Rev Endocr Metab Disord . 2023 Jul; 24(5):921-936. PMID: 37402955
Obesity is a heterogenous disease accompanied by a broad spectrum of cardiometabolic risk profiles. Traditional paradigms for dietary weight management do not address biological heterogeneity between individuals and have catastrophically...
3.
Dunne S, McGillicuddy F, Gibney E, Feeney E
Am J Clin Nutr . 2023 Feb; 117(1):111-120. PMID: 36789929
Background: Intake of dairy fat within the matrix of cheese lowered circulating LDL cholesterol concentration to a greater extent than the same components consumed separately as butter, protein, and calcium....
4.
Howe A, Burke S, OReilly M, McGillicuddy F, Costello D
Mol Neurobiol . 2022 Jan; 59(4):2348-2362. PMID: 35079937
The relationship between systemic immunity and neuroinflammation is widely recognised. Infiltration of peripheral immune cells to the CNS during certain chronic inflammatory states contributes significantly to neuropathology. Obesity and its...
5.
Kajani S, Curley S, OReilly M, Yin X, Dillon E, Guo W, et al.
Mol Metab . 2021 Dec; 56:101425. PMID: 34954383
Introduction: High-fat diet (HFD)-induced obesity impairs clearance of cholesterol through the Reverse Cholesterol Transport (RCT) pathway, with downregulation in hepatic expression of cholesterol and bile acid transporters, namely ABCG5/8 and...
6.
Ahmed M, Byrne R, Pazderska A, Segurado R, Guo W, Gunness A, et al.
Diabetologia . 2020 Nov; 64(3):656-667. PMID: 33169205
Aims/hypothesis: The prevalence of atherosclerosis is increased in type 1 diabetes despite normal-to-high HDL-cholesterol levels. The cholesterol efflux capacity (CEC) of HDL is a better predictor of cardiovascular events than...
7.
Curley S, Gall J, Byrne R, Yvan-Charvet L, McGillicuddy F
Mol Nutr Food Res . 2020 Aug; 65(1):e1900482. PMID: 32754976
Metabolic inflammation is a classic hallmark of obesity that is associated with numerous cardiometabolic complications. Disturbances in fatty acid and cholesterol metabolism are evident in obesity and likely intricately linked...
8.
Ralston J, Mitchelson K, Lynch G, Tran T, Wang H, Strain C, et al.
Mol Nutr Food Res . 2020 Jun; 65(1):e2000202. PMID: 32558187
Scope: IL-1RI-mediated inflammatory signaling alters metabolic tissue responses to dietary challenges (e.g., high-fat diet [HFD]). Recent work suggests that metabolic phenotype is transferrable between mice in a shared living environment...
9.
Ralston J, Nguyen-Tu M, Lyons C, Cooke A, Murphy A, Falvey A, et al.
Br J Nutr . 2020 Mar; 124(3):247-255. PMID: 32122411
Preliminary evidence has suggested that high-fat diets (HFD) enriched with SFA, but not MUFA, promote hyperinsulinaemia and pancreatic hypertrophy with insulin resistance. The objective of this study was to determine...
10.
OReilly M, Lenighan Y, Dillon E, Kajani S, Curley S, Bruen R, et al.
Mol Nutr Food Res . 2020 Jan; 64(7):e1900599. PMID: 31917888
Scope: High-fat diet (HFD)-induced obesity impairs macrophage-to-feces reverse cholesterol transport (RCT). It is hypothesized that dietary supplementation with the polyunsaturated fatty acids conjugated linoleic acid (CLA) or alpha linolenic acid...